FDA-Device2026-02-11Class IIMISBRANDING
Siemens NAEOTOM Alpha.Pro CT brain software recalled for lacking FDA clearance
Remove Siemens NAEOTOM brain software from your CT system
Siemens Medical Solutions USA is recalling three brain analysis software applications (syngo.CT Brain Quantification, syngo.CT Vessel Hyperdensities, and syngo.CT ASPECTS) installed on certain NAEOTOM Alpha.Pro CT systems. These applications were not cleared by the FDA before being distributed and must be removed from affected devices.
- If your facility operates a NAEOTOM Alpha.Pro CT system, contact Siemens Medical Solutions to determine if your unit is affected
- Remove the three named software applications from your system immediately if you have them installed
- Contact Siemens for instructions on safe removal and any replacement software options
Hazard
To remove the software applications from certain CT systems as the applications have not received FDA 510(k) clearance.
Who it affects
Adults
Illnesses reported
None reported
Sold states
Worldwide distribution - US Nationwide and the countries of Canada, Costa Rica, India, Israel.
Affected count
2 units
Manufactured in
40 Liberty Blvd, N/A, Malvern, PA, United States
Products
NAEOTOM Alpha.Pro Software applications: syngo.CT Brain Quantification syngo.CT Vessel Hyperdensities syngo.CT ASPECTS
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1242-2026More Siemens recalls
- FDA-Device2026-07-08Siemens ARTIS icono ceiling model 11328100 recalled for loss of movement capability
- FDA-Device2026-07-08Siemens ARTIS icono biplane recalled for potential loss of movement after detector adjustment
- FDA-Device2026-07-08Siemens ARTIS icono floor recalled for potential movement loss at detector height limits
- FDA-Device2026-07-08Siemens ARTIS icono ceiling monitor suspension recalled for loose screw risk
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief